Related Experiment Video
Updated: May 15, 2026

10:41
A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
Published on: April 30, 2020
[Acute miliary tuberculosis or Isambert disease: a case report].
1Service d'ORL et chirurgie cervico-faciale, CHU Mohammed VI, Marrakech, Maroc. ziad.tarik.orl@gmail.com
Summary
Pharyngeal tuberculosis, a rare but increasing infection, presents as throat lesions from Mycobacterium tuberculosis. Early diagnosis and antituberculous chemotherapy are crucial for favorable outcomes in head and neck cases.
Area of Science:
- Infectious Diseases
- Otolaryngology
- Pediatrics
Background:
- Pharyngeal tuberculosis involves active, granulomatous lesions in the pharyngeal mucosa caused by Mycobacterium tuberculosis.
- An upsurge in tuberculosis cases necessitates considering pharyngeal involvement in endemic regions, especially with head and neck symptoms.
Observation:
- A 9-year-old girl presented with dysphagia, pharyngeal discomfort, snoring, and hoarseness for 8 months, indicative of a pharyngeal syndrome.
- Clinical examination revealed diffuse oropharyngeal mucosal granulation, accompanied by an impaired general condition.
- Diagnostic workup identified an inflammatory syndrome, a strongly positive intradermal tuberculin reaction, and a biopsy showing giant cell granuloma with caseous necrosis.
Findings:
- The case highlights acute miliary tuberculosis manifesting as pharyngeal lesions.
- Histopathological analysis confirmed granulomatous inflammation with caseous necrosis, characteristic of tuberculosis.
- The patient's condition improved significantly with antituberculous chemotherapy.
Implications:
- This case underscores the importance of suspecting pharyngeal tuberculosis in endemic areas, particularly with persistent head and neck symptoms.
- Prompt diagnosis through clinical evaluation, tuberculin testing, and biopsy is essential.
- Effective antituberculous chemotherapy leads to favorable outcomes, emphasizing the treatability of this rare condition.
Related Concept Videos
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...